Clene Inc.
NASDAQ:CLNN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Clene Inc.
NASDAQ:CLNN
|
US |
|
A
|
ALT Telecom PCL
SET:ALT
|
TH |
|
CloudMD Software & Services Inc
F:6PH
|
CA |
|
O
|
OFS Capital Corp
F:9UD
|
US |
|
D
|
Defense Metals Corp
F:35D
|
CA |
|
G
|
Graham Holdings Co
DUS:WPOB
|
US |
|
A
|
Advantest Corp
F:VAN
|
JP |
|
E
|
Esotiq & Henderson SA
WSE:EAH
|
PL |
|
Arkema SA
OTC:ARKAY
|
FR |
|
S
|
Samart Corporation PCL
SET:SAMART
|
TH |
Intrinsic Value
Is CLNN undervalued or overvalued?
See the intrinsic value estimate for Clene Inc. and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Clene Does
Clene Inc. is a clinical-stage biopharmaceutical company that develops experimental medicines for serious neurodegenerative and neurological diseases. Its lead programs are aimed at conditions such as ALS, multiple sclerosis, and other disorders where nerve cells are damaged and the body has limited treatment options. The company’s core work is drug research, clinical testing, and building evidence that its therapies can protect or restore nerve cell function.
- Headquarters
- United States of America US
- Employees
- 95
- IPO date
- Aug 27, 2018
Revenue & Expenses Breakdown
Clene Inc.
Earnings Waterfall
Clene Inc.
The intrinsic value for Clene Inc. (CLNN) under the Base Case is hidden USD.
Compared with the current market price of 3.9 USD, the stock appears hidden.